Home
BioArctic and Novartis Sign a Collaboration and License Agreement Using BrainTransporter™

BioArctic and Novartis Sign a Collaboration and License Agreement Using BrainTransporter™

Today’s Highlights August 27, 2025

BioArtic AB & Novartis Sign Agreement
Stockholm, Sweden, August 26, 2025 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that the company has entered into an option, collaboration and license agreement with Novartis Pharma AG (This content is for paid subscribers.

Please click here to subscribe or here to log in.
Today’s Highlights
,
August 27, 2025

Other Articles